IRVINE, Calif., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and ...
New data from the PROMISE III trial show the LimFlow transcatheter deep venous arterialization system achieved over 80% amputation-free survival at six months in 'no-option' chronic limb-threatening ...
The US Food and Drug Administration (FDA) has approved an endovascular device for patients with chronic limb-threatening ischemia (CLTI) at risk for major amputation who are poor candidates for ...
DETROIT (March 21, 2024) – The first commercial procedure on a patient in Michigan using the LimFlow System was performed earlier this month by vascular and endovascular surgeon Tamer Boules, M.D., ...
SINGAPORE - Media OutReach - 18 September 2023-M&L Healthcare, in its first major MedTech investment, has announced that the U.S. Food and Drug Administration (FDA) has granted premarket approval (PMA ...
MIAMI, Nov. 7, 2024 /PRNewswire/ -- Pedro Martinez-Clark, MD, FACC, a renowned Harvard-trained cardiologist and founder of Amavita Heart and Vascular ™, has joined forces with LimFlow ® to offer an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results